Literature DB >> 11753945

Apoptosis and proliferation in hepatocarcinogenesis related to cirrhosis.

Y N Park1, K J Chae, Y B Kim, C Park, N Theise.   

Abstract

BACKGROUND: Dysplastic nodules (DNs) recently have been identified as preneoplastic lesions of hepatocellular carcinoma (HCC). To test an alternative hypothesis regarding DN development, in which we have suggested that DNs develop as an infiltrating clonal expansion in advance of, or parallel to cirrhosis, the authors investigated the rates of apoptosis and proliferation in human hepatocarcinogenesis.
METHODS: The authors performed terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) assay and proliferation cell nuclear antigen (PCNA) staining in 11 low-grade DNs, 8 high-grade DNs including 3 cases with HCC subnodules, 10 small HCCs, and 29 cases of surrounding cirrhotic nodules. Hepatocellular carcinoma subnodules were present in three cases of high DNs. They determined TUNEL-labeling indices (LIs) and PCNA-LIs as the percentage of positive hepatocyte nuclei per 500 randomly counted cells.
RESULTS: TUNEL-LIs (mean +/- standard deviation) were 0.8 +/- 0.82 in cirrhotic nodules, 1.0 +/- 0.98 in low-grade DNs, 3.0 +/- 4.33 in high-grade DNs, 8.7 +/- 7.71 in HCC subnodules of high-grade DNs, and 3.2 +/- 3.58 in small HCCs. The peak values of apoptotic activity were higher in high-grade DNs and HCCs than in low-grade DNs and cirrhotic nodules. Each case of low-grade DN showed a low to medium level of apoptotic activity when compared with those of the four surrounding cirrhotic nodules. The PCNA-LIs were 2.6 +/- 1.35 in cirrhotic nodules, 4.5 +/- 2.31 in low-grade DNs, 15.3 +/- 10.50 in high-grade DNs, 25.4 +/- 5.25 in HCC subnodules of high-grade DNs, and 34.9 +/- 15.70 in small HCCs. The peak values gradually increased, although only HCC showed significantly elevated proliferation activity. The differences of PCNA-LIs and TUNEL-LIs, measured in each case, were 1.7 +/- 1.89 in cirrhotic nodules, 3.6 +/- 2.43 in low-grade DNs, 7.9 +/- 5.69 in high-grade DNs, 16.2 +/- 2.87 in HCC subnodules of high-grade DNs, 28.2 +/- 13.97 in small HCCs. At all stages of hepatocarcinogenesis, the rates of cell proliferation were higher than apoptosis, allowing a preferential net gain of (pre)neoplastic cells, and it was significantly increased in small HCCs. In regenerative cirrhotic nodules, 14% (4 cases) showed higher rates of apoptosis than proliferation.
CONCLUSIONS: The regulation/dysregulation of apoptosis of (pre)neoplastic cells as well as of proliferation may play an important role in the process of hepatocarcinogenesis. Copyright 2001 American Cancer Society.

Entities:  

Mesh:

Year:  2001        PMID: 11753945     DOI: 10.1002/1097-0142(20011201)92:11<2733::aid-cncr10126>3.0.co;2-5

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  18 in total

1.  Telomerase activity and hepatic functions of rat embryonic liver progenitor cell in nanoscaffold-coated model bioreactor.

Authors:  Shibashish Giri; Karen Nieber; Ali Acikgöz; Sanja Pavlica; Mario Keller; Augustinus Bader
Journal:  Mol Cell Biochem       Date:  2009-10-09       Impact factor: 3.396

Review 2.  Apoptosis in liver carcinogenesis and chemotherapy.

Authors:  Joaquim Moreno-Càceres; Isabel Fabregat
Journal:  Hepat Oncol       Date:  2015-11-11

3.  Correlation between expression of gastrin, somatostatin and cell apoptosis regulation gene bcl-2/bax in large intestine carcinoma.

Authors:  Jia-Ding Mao; Pei Wu; Xiang-Hou Xia; Ji-Qun Hu; Wen-Bin Huang; Guo-Qiang Xu
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

4.  Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells.

Authors:  Han Chu Lee; Bo Tian; John M Sedivy; Jack R Wands; Miran Kim
Journal:  Gastroenterology       Date:  2006-10       Impact factor: 22.682

5.  Decreased apoptosis in advanced-stage/high-grade hepatocellular carcinoma complicating chronic hepatitis C is mediated through the downregulation of p21 ras.

Authors:  Nahed Baddour; Ebtehal Farrag; Ahmed Zeid; Essam Bedewy; Yousry Taher
Journal:  Chin J Cancer Res       Date:  2013-06       Impact factor: 5.087

6.  Expression of fragile histidine triad in primary hepatocellular carcinoma and its relation with cell proliferation and apoptosis.

Authors:  Ke-Jun Nan; Zhi-Ping Ruan; Zhao Jing; Hai-Xia Qin; Hong-Yan Wang; Hui Guo; Rui Xu
Journal:  World J Gastroenterol       Date:  2005-01-14       Impact factor: 5.742

7.  Pseudomonas aeruginosa: mannose sensitive hemagglutinin inhibits the growth of human hepatocarcinoma cells via mannose-mediated apoptosis.

Authors:  Zhenyuan Cao; Lijun Shi; Ying Li; Jinghua Wang; Dandan Wang; Guangyou Wang; Bo Sun; Lili Mu; Mingfei Yang; Hulun Li
Journal:  Dig Dis Sci       Date:  2008-12-04       Impact factor: 3.199

8.  Expression and clinical significance of NET-1 and PCNA in hepatocellular carcinoma.

Authors:  Shi-Qiang Shen; Kun Li; Neng Zhu; Akimasa Nakao
Journal:  Med Oncol       Date:  2008-01-23       Impact factor: 3.064

Review 9.  Putative roles of hepatitis B x antigen in the pathogenesis of chronic liver disease.

Authors:  Mark A Feitelson; Helena M G P V Reis; N Lale Tufan; Bill Sun; Jingbo Pan; Zhaorui Lian
Journal:  Cancer Lett       Date:  2009-02-06       Impact factor: 8.679

Review 10.  Role of sex steroid receptors in pathobiology of hepatocellular carcinoma.

Authors:  Mamta Kalra; Jary Mayes; Senait Assefa; Anil-K Kaul; Rashmi Kaul
Journal:  World J Gastroenterol       Date:  2008-10-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.